drugset / Trial / NCT06419777

Strict Versus Permissive Thresholds for Initiation of Pharmacotherapy in Gestational Diabetes

NCT06419777

RandomizedParallel-groupOpen-labelTreatment

Summary

The aim of our study is to compare neonatal and maternal outcomes using different thresholds for the initiation and titration of pharmacotherapy for gestational diabetes (GDM). Our goal is to compare a strict and permissive threshold. The strict threshold is defined as two abnormal values or more over a one-week period (two fasting values elevated, two of the same post prandial values elevated, or 1 fasting and 1 post prandial value elevated), whereas the permissive threshold is defined as 50% of values elevated over 1 week (50% of overall fasting values, 50% of postprandial values, or 50% of overall values).

Timeline

Start
2024-09-01
Primary completion
2026-05
Completion
2026-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Insulin Lispro Protein / enzyme biologic
Subject NPH Unknown
Subject insulin detemir Protein / enzyme biologic
Subject insulin glargine Protein / enzyme biologic

Indications